Development of a device to monitor HIV viral load and medication adherence
Official title: NIMH SBIR PHASE 1 TOPIC 001- POINT-OF-CARE HIV VIRAL LOAD AND DRUG ADHERENCE ASSAYS
Funded at Vitruvian Bio, LLC · NIH-11222472 · Data updated 2026-11-12
This study is testing a new device that helps people with HIV check their viral load and medication levels at home, so they can stay informed about their health and share important information with their doctors.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vitruvian Bio, LLC NIH-funded |
| Lab location | 1 site (Ellicott City, United States) |
| Project start | September 23, 2024 |
| Project end | September 22, 2025 |
| Funding year | 2024 |
| Award (this year) | $299,999 |
| NIH project number | 75N95024C00040-0-9999-1 |
| Project ID | NIH-11222472 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals living with HIV who are currently undergoing treatment and are interested in self-monitoring their health.
✕Less likely to help
Patients who are not living with HIV or those who are not on antiretroviral therapy may not benefit from this research.
What this research studies
This research focuses on creating a device that allows individuals living with HIV to monitor their viral load and medication adherence at home or in a point-of-care setting. The device will provide qualitative results regarding the levels of HIV in the body and the concentration of therapeutic drugs. This information can be shared with healthcare providers to ensure effective treatment and management of HIV. The goal is to empower patients with real-time data about their health status, improving their ability to manage their condition.
Why it matters
Potential benefit: If successful, this research could enable patients to better manage their HIV treatment and improve health outcomes through timely monitoring.
How similar studies have gone: Similar approaches in HIV monitoring have shown promise, indicating potential for success in this novel device development.
Where this research is happening
-
Vitruvian Bio, LLC
Ellicott City, United States Active
Researchers
- Principal investigator: Senpen, Angana — Vitruvian Bio, LLC
- Study coordinator: Senpen, Angana
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.